Bolsa PT - Gráfico 5 Dias e Resumo de Sepracor Inc. [SEPR]

Sepracor Inc. - [Ticker: SEPR]
Última Trade	0,000	Range 52 Semanas	[0,000 - 0,000]
Hora da Última Trade	- 00:00:00	Price-Target 1 Ano	0,000
Variação	N/A (N/A)	Capitalização Bolsista	0
Bid / Ask	N/A	EPS	0,00
Abertura	0,000	PER	0,00%
Máximo	0,000	Pagamento Dividendo
Mínimo	0,000	Data Ex-Dividendo
Fecho Anterior	0,000	Yield
Volume	0	Volume Médio (3m)	0
Nota: Os dados podem apresentar atraso de alguns minutos.

Ver cotações de outros activos

Intraday 5 dias 1 mes 3 meses 6 meses 1 ano 2 anos 5 anos 10 anos Use este gráfico no seu website!
Gráfico de Sepracor Inc. - [Ticker: SEPR]

Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:

Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)

Asthma Medication Market Analysis by Professional Reviews and Opinions 2018
Trade Market Research
In 2017, the global Asthma Medication market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The Global Asthma Medication Market Report provides a complete market analysis of the ...

County Telegram

Global Asthma Medication Market Research Study including Growth Factors, Competitive Analysis by regions And Top ...
County Telegram
Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The regional examination has been done to precisely ...

Latest Market Reports By Abhishek Budholiya (press release) (blog)

Expansion of Allergy Treatment Market During 2016-2026 to Gain Robust Traction
Latest Market Reports By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

Allergan Medicaid Rebate Suit Redo Denied At 3rd Circ.
Law360
Law360 (September 26, 2018, 7:11 PM EDT) -- The Third Circuit on Wednesday again refused to revive a pharmaceutical executive's suit claiming Allergan Inc. and other drug manufacturers shorted the federal government on drug rebate payments.

Global Banking And Finance Review (press release)

Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis Appointed as CEO
Global Banking And Finance Review (press release)
On September 4, 2018, Nautic Partners, LLC (Nautic) completed the acquisition of Mikart, Inc. (Mikart or the Company) and appointed Michael Kallelis as CEO of the Company. Headquartered in Atlanta, GA, Mikart is a leading contract development and ...
Nautic Partners buys MikartPE Hub (blog)

todos os 9 artigos de notícias »

LANews By Abhishek Budholiya (press release) (blog)

Allergy Treatment Market to Register Steady Expansion During 2016-2026
LANews By Abhishek Budholiya (press release) (blog)
... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

e mais »

OutSourcing-Pharma.com

GA-based CDMO picked up by private equity
OutSourcing-Pharma.com
Mikart, Inc. provides a range of services, including formulation development, clinical trial supplies, regulatory filing support, as well as clinical and commercial manufacturing, among others. According to the company, ongoing investments in the ...

WhaTech

Global Asthma Medication Market Research Report for 2018 scrutinized in new research
WhaTech
Top Key Players. Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The territorial examination has been ...

The Future Gadgets

Desloratadine Market Industry- 2018 Marketable Price, Growth Rate and Product Development Analysis 2023
The Future Gadgets
Pfizer; Teva; Wante Pharmaceutical; Novartis India Limited; Mylan; Sepracor; Sandoz; Apollo Pharmaceuticals; GSK; Mayne Pharma Inc; Abhilasha Pharma Pvt; Abbott; Takeda; Schering-Plough; Nanjing Hicin Pharmaceutical; Hairui Pharmaceutical; Hainan ...

e mais »

Photocure ASA: Daniel Schneider appointed Chief Executive Officer
GlobeNewswire (press release)
Mr Schneider has also held executive management positions in other pharmaceutical and biotech companies, including BTG International, Somaxon Pharmaceuticals and Sepracor. ... The US headquarters for Photocure Inc., are in Princeton, New Jersey.

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...

Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
Business Wire (press release)
She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...

Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors
Business Wire (press release)
BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.